Hui Hua Selected Research

Biomarkers (Surrogate Marker)

2/2024	Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model.
1/2021	Targeting Akt in cancer for precision therapy.
1/2019	miR-124 Functions As A Melanoma Tumor Suppressor By Targeting RACK1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Hua Research Topics

Disease

51	Neoplasms (Cancer) 03/2024 - 06/2005
11	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2008
10	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2012
8	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2011
6	Inflammation (Inflammations) 02/2024 - 01/2015
6	Carcinogenesis 01/2024 - 10/2010
5	Fibrosis (Cirrhosis) 02/2024 - 01/2016
5	Infections 01/2023 - 01/2016
4	Clonorchiasis 01/2022 - 01/2016
3	Cicatrix (Scar) 01/2024 - 06/2023
3	Acne Vulgaris 01/2024 - 06/2023
2	Liver Neoplasms (Liver Cancer) 01/2024 - 12/2019
2	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 09/2018
2	Cataract (Cataracts) 08/2023 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2022
2	Liver Diseases (Liver Disease) 01/2022 - 01/2016
2	Multiple Sclerosis 05/2021 - 01/2019
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2021 - 01/2019
2	Demyelinating Diseases (Demyelinating Disease) 05/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 04/2021 - 08/2009
2	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 10/2020
2	Pathologic Processes 11/2020 - 01/2016
2	Lymphatic Metastasis 10/2020 - 09/2018
2	Arthritis (Polyarthritis) 01/2020 - 03/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2002 - 09/2002
1	Sclerosing Cholangitis 02/2024
1	Wounds and Injuries (Trauma) 02/2024
1	Fibrosarcoma 01/2024
1	Stomach Neoplasms (Stomach Cancer) 11/2023
1	Autoimmune Diseases (Autoimmune Disease) 09/2023
1	Heart Injuries 09/2023

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 02/2024 - 06/2016
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2005
4	Small Interfering RNA (siRNA)IBA 11/2021 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2019
3	Therapeutic UsesIBA 02/2024 - 01/2019
3	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2016
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2024 - 01/2008
3	CateninsIBA 11/2023 - 09/2014
3	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2015
3	gamma-Synuclein (Persyn)IBA 01/2022 - 03/2009
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2013
3	Somatomedin Receptors (Somatomedin Receptor)IBA 11/2021 - 08/2015
3	Estrogen ReceptorsIBA 09/2018 - 06/2011
3	Caspase 7IBA 09/2013 - 03/2009
3	Endoplasmic Reticulum Chaperone BiPIBA 01/2010 - 09/2009
2	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 03/2024 - 01/2024
2	rheinIBA 01/2024 - 01/2018
2	Sincalide FDA Link 07/2023 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 06/2023 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 05/2022 - 01/2022
2	InterleukinsIBA 01/2022 - 01/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2022
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022 - 12/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022 - 05/2021
2	IntegrinsIBA 01/2022 - 04/2021
2	Sorafenib (BAY 43-9006)FDA Link 11/2021 - 03/2016
2	LigandsIBA 11/2021 - 12/2019
2	Long Noncoding RNAIBA 05/2021 - 10/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2021 - 01/2018
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 03/2016
2	Estrogens (Estrogen)FDA Link 01/2018 - 06/2011
2	Aflatoxin B1 (Aflatoxin B)IBA 08/2015 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 01/2012
2	saracatinibIBA 08/2015 - 01/2015
2	MutagensIBA 08/2015 - 01/2012
2	Insulin-Like Growth Factor I (IGF-1)IBA 09/2014 - 10/2010
2	Caspase 3 (Caspase-3)IBA 09/2013 - 03/2009
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2012 - 10/2010
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2010 - 11/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2010 - 09/2009
2	TeaIBA 01/2010 - 11/2009
1	snake venom protein C activatorIBA 03/2024
1	Proteolysis Targeting ChimeraIBA 03/2024
1	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 02/2024
1	XenobioticsIBA 02/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2024
1	ColforsinIBA 01/2024
1	artemisinin (artemisinine)IBA 01/2024
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2024
1	ArtesunateIBA 01/2024
1	erythromycin propionate-N-acetylcysteinateIBA 01/2024
1	Androgen Receptors (Androgen Receptor)IBA 12/2023
1	Janus Kinase InhibitorsIBA 09/2023
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023

Therapy/Procedure

19	Therapeutics 01/2024 - 11/2009
5	Drug Therapy (Chemotherapy) 01/2022 - 09/2009
3	Gas Lasers 01/2024 - 02/2022
3	Aftercare (After-Treatment) 06/2023 - 01/2018
2	Immunotherapy 01/2024 - 01/2023
2	Chemoprevention 01/2019 - 11/2009
2	Radiotherapy 08/2012 - 10/2008
2	Induction Chemotherapy 12/2002 - 09/2002